Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 2001 Jun; 60(6): 545–548.
PMCID: PMC1753662

Markers of joint destruction: principles, problems, and potential

Full Text

The Full Text of this article is available as a PDF (127K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, Haanen HC, Hofman DM, van Albada-Kuipers GA, ter Borg EJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med. 1996 Apr 15;124(8):699–707. [PubMed]
  • Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, Joseph L, Bombardier C, Esdaile JM. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol. 2000 Mar;27(3):623–629. [PubMed]
  • Young A, van der Heijde DM. Can we predict aggressive disease? Baillieres Clin Rheumatol. 1997 Feb;11(1):27–48. [PubMed]
  • Garnero P, Rousseau JC, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum. 2000 May;43(5):953–968. [PubMed]
  • Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000 Sep;43(9):1916–1926. [PubMed]
  • Eastell R, Robins SP, Colwell T, Assiri AM, Riggs BL, Russell RG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int. 1993 Sep;3(5):255–260. [PubMed]
  • Heinegård D, Saxne T. Molecular markers of processes in cartilage in joint disease. Br J Rheumatol. 1991;30 (Suppl 1):21–24. [PubMed]
  • Greenwald RA. Monitoring collagen degradation in patients with arthritis. The search for suitable surrogates. Arthritis Rheum. 1996 Sep;39(9):1455–1465. [PubMed]
  • Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B. Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol. 1998 Dec;25(12):2339–2344. [PubMed]
  • Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum. 1995 Jul;38(7):902–906. [PubMed]
  • Sharif M, Salisbury C, Taylor DJ, Kirwan JR. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum. 1998 Jul;41(7):1203–1209. [PubMed]
  • Hein G, Franke S, Müller A, Bräunig E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol. 1997 Mar;16(2):167–172. [PubMed]
  • Müller A, Hein G, Franke S, Herrmann D, Henzgen S, Roth A, Stein G. Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography. Rheumatol Int. 1996;16(1):23–28. [PubMed]
  • Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford) 2000 Jul;39(7):742–744. [PubMed]
  • Garnero P, Jouvenne P, Buchs N, Delmas PD, Miossec P. Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. Bone. 1999 Apr;24(4):381–385. [PubMed]
  • Tohmé JF, Seibel MJ, Silverberg SJ, Robins SP, Bilezikian JP. Biochemical markers of bone metabolism. Z Rheumatol. 1991 May-Jun;50(3):133–141. [PubMed]
  • Saxne T, Zunino L, Heinegård D. Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):82–90. [PubMed]
  • Månsson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegård D, Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest. 1995 Mar;95(3):1071–1077. [PMC free article] [PubMed]
  • Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis. 1997 May;56(5):299–307. [PMC free article] [PubMed]
  • Harvey S, Weisman M, O'Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C. Chondrex: new marker of joint disease. Clin Chem. 1998 Mar;44(3):509–516. [PubMed]
  • Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 1993 Sep;36(9):1214–1222. [PubMed]
  • Salisbury C, Sharif M. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood. Ann Rheum Dis. 1997 Sep;56(9):558–561. [PMC free article] [PubMed]
  • Poole AR, Webber C, Reiner A, Roughley PJ. Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency. Biochem J. 1989 Jun 15;260(3):849–856. [PMC free article] [PubMed]
  • Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997 Apr 1;99(7):1534–1545. [PMC free article] [PubMed]
  • Saxne T, Glennås A, Kvien TK, Melby K, Heinegård D. Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum. 1993 Jan;36(1):20–25. [PubMed]
  • Manicourt DH, Fujimoto N, Obata K, Thonar EJ. Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum. 1994 Dec;37(12):1774–1783. [PubMed]

Figures and Tables

Figure 1
Biochemical markers of tissue destruction, inflammation, and repair. Abbreviations and examples of references referring to the use of these markers: S = synthesis marker; D = degradation marker. PINP = amino-terminal ...

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...